A re-assessment of 4CMenB vaccine effectiveness against serogroup B invasive meningococcal disease in England based on an incidence model

被引:0
作者
Lorenzo Argante
Victoria Abbing-Karahagopian
Kumaran Vadivelu
Rino Rappuoli
Duccio Medini
机构
[1] GSK,
[2] GSK,undefined
来源
BMC Infectious Diseases | / 21卷
关键词
Invasive meningococcal disease; IMD; MenB; 4CMenB; Bexsero; Effectiveness; VE; Incidence model; Screening method; Epidemiology;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 72 条
[1]  
Stephens DS(2007)Epidemic meningitis, meningococcaemia, and Neisseria meningitidis Lancet 369 2196-2210
[2]  
Greenwood B(2019)The Global Meningococcal Initiative meeting on prevention of meningococcal disease worldwide: epidemiology, surveillance, hypervirulent strains, antibiotic resistance and high-risk populations Expert Rev Vaccines 18 15-30
[3]  
Brandtzaeg P(2012)Toward a meningitis-free world Sci Transl Med 4 123ps5-123ps5-298
[4]  
Acevedo R(2010)The epidemiology of meningococcal disease and the impact of vaccines Expert Rev Vaccines 9 285-1346
[5]  
Bai X(2015)Global incidence of serogroup B invasive meningococcal disease: a systematic review Lancet Infect Dis 15 1334-1326
[6]  
Borrow R(1969)Human immunity to the meningococcus. I. The role of humoral antibodies J Exp Med 129 1307-2782
[7]  
Black S(2016)Effectiveness and impact of a reduced infant schedule of 4CMenB vaccine against group B meningococcal disease in England: a national observational cohort study Lancet 388 2775-317
[8]  
Pizza M(2020)Vaccination of infants with meningococcal group B vaccine (4CMenB) in England N Engl J Med 382 309-1068
[9]  
Nissum M(1985)Field evaluation of vaccine efficacy Bull World Health Organ 63 1055-746
[10]  
Rappuoli R(1993)Estimation of vaccine effectiveness using the screening method Int J Epidemiol 22 742-e90